Works about PIROXICAM
Results: 458
Tratamiento multimodal para lumbalgia crónica inespecífica.
- Published in:
- Acta Ortopédica Mexicana, 2010, v. 24, n. 2, p. 88
- By:
- Publication type:
- Article
The impact of toceranib, piroxicam and thalidomide with or without hypofractionated radiation therapy on clinical outcome in dogs with inflammatory mammary carcinoma.
- Published in:
- Veterinary & Comparative Oncology, 2018, v. 16, n. 4, p. 497, doi. 10.1111/vco.12407
- By:
- Publication type:
- Article
Risk factors for treatment-related adverse events in cancer-bearing dogs receiving piroxicam.
- Published in:
- Veterinary & Comparative Oncology, 2017, v. 15, n. 4, p. 1346, doi. 10.1111/vco.12276
- By:
- Publication type:
- Article
Effects of low-dose cyclophosphamide with piroxicam on tumour neovascularization in a canine oral malignant melanoma-xenografted mouse model.
- Published in:
- Veterinary & Comparative Oncology, 2015, v. 13, n. 4, p. 424, doi. 10.1111/vco.12059
- By:
- Publication type:
- Article
Primary frontal sinus squamous cell carcinoma in three dogs treated with piroxicam combined with carboplatin or toceranib.
- Published in:
- Veterinary & Comparative Oncology, 2012, v. 10, n. 3, p. 206, doi. 10.1111/j.1476-5829.2011.00292.x
- By:
- Publication type:
- Article
Safety evaluation of combination toceranib phosphate (Palladia®) and piroxicam in tumour-bearing dogs (excluding mast cell tumours): a phase I dose-finding study Safety evaluation of combination toceranib phosphate (Palladia®) and piroxicam in tumour-bearing dogs (excluding mast cell tumours): a phase I dose-finding study
- Published in:
- Veterinary & Comparative Oncology, 2012, v. 10, n. 3, p. 184, doi. 10.1111/j.1476-5829.2011.00265.x
- By:
- Publication type:
- Article
Abstracts presented at the 25th Annual VCS Conference, Huntington Beach, CA, USA, 20-23 October 2005.
- Published in:
- 2006
- Publication type:
- Abstract
Carboplatin and piroxicam therapy in 31 dogs with transitional cell carcinoma of the urinary bladder.
- Published in:
- Veterinary & Comparative Oncology, 2005, v. 3, n. 2, p. 73, doi. 10.1111/j.1476-5810.2005.00070.x
- By:
- Publication type:
- Article
The effect of deracoxib and piroxicam on viability of canine osteosarcoma cells in vitro.
- Published in:
- Veterinary & Comparative Oncology, 2005, v. 3, n. 1, p. 54, doi. 10.1111/j.1476-5810.2005.064ah.x
- By:
- Publication type:
- Article
Results of the Combined Treatment with Piroxicam and Carboplatin in Canine Oral Non-Tonsillar Squamous Cell Carcinoma.
- Published in:
- Veterinary & Comparative Oncology, 2005, v. 3, n. 1, p. 42, doi. 10.1111/j.1476-5810.2005.0064q.x
- By:
- Publication type:
- Article
Piroxicam and carboplatin as a combination treatment of canine oral non-tonsillar squamous cell carcinoma: a pilot study and a literature review of a canine model of human head and neck squamous cell carcinoma.
- Published in:
- Veterinary & Comparative Oncology, 2005, v. 3, n. 1, p. 16, doi. 10.1111/j.1476-5810.2005.00065.x
- By:
- Publication type:
- Article
SERS of the anti-inflammatory drug piroxicam adsorbed on the surface of silver or gold colloids as nanocarrier model.
- Published in:
- Journal of Raman Spectroscopy, 2016, v. 47, n. 4, p. 402, doi. 10.1002/jrs.4839
- By:
- Publication type:
- Article
Comparison of intra-articular bupivacaine-morphine with bupivacaine-tenoxicam combinations on post-operative analgesia in patients with arthroscopic meniscectomy: a prospective, randomised study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Piroxicam ex vivo release kinetics from zein/pectin delivery systems.
- Published in:
- Pharmaceutical Chemistry Journal, 2012, v. 46, n. 6, p. 378, doi. 10.1007/s11094-012-0803-3
- By:
- Publication type:
- Article
Kinetics of piroxicam release from low-methylated pectin/zein hydrogel microspheres.
- Published in:
- Pharmaceutical Chemistry Journal, 2012, v. 46, n. 1, p. 50, doi. 10.1007/s11094-012-0732-1
- By:
- Publication type:
- Article
Compatibility studies between piroxicam and pharmaceutical excipients used in solid dosage forms.
- Published in:
- Pharmaceutical Chemistry Journal, 2008, v. 42, n. 4, p. 215, doi. 10.1007/s11094-008-0091-0
- By:
- Publication type:
- Article
XPS study of pharmacological substances mechanochemically immobilized on the surface of alumina.
- Published in:
- Journal of Structural Chemistry, 2011, v. 52, p. 137, doi. 10.1134/S0022476611070183
- By:
- Publication type:
- Article
Comparison of Local Anesthesia and Analgesic Effects of Piroxicam in Aspiration Curettage.
- Published in:
- Haydarpasa Numune Medical Journal, 2024, v. 64, n. 3, p. 327, doi. 10.14744/hnhj.2023.93899
- By:
- Publication type:
- Article
Effectiveness of Single Dose Premedication of Piroxicam and Prednisolone on Post Endodontic Pain in One Visit Root Canal Treatment: A Randomized Clinical Trial.
- Published in:
- European Endodontic Journal, 2022, v. 7, n. 3, p. 187, doi. 10.14744/eej.2022.24119
- By:
- Publication type:
- Article
Electrochemical Degradation of Piroxicam on a Boron‐Doped Diamond Anode: Investigation of Operating Parameters and Ultrasound Synergy.
- Published in:
- ChemElectroChem, 2019, v. 6, n. 3, p. 841, doi. 10.1002/celc.201800971
- By:
- Publication type:
- Article
Comparison of the adverse renal effects of different types of NSAID based on COX inhibition in patients with headaches.
- Published in:
- Macedonian Pharmaceutical Bulletin / Makedonsko Farmacevtski Bilten, 2020, v. 66, n. 1, p. 3, doi. 10.33320/maced.pharm.bull.2020.66.01.006
- By:
- Publication type:
- Article
Solubility and Preferential Solvation of Piroxicam in Neat Solvents and Binary Systems.
- Published in:
- Zeitschrift für Physikalische Chemie, 2018, v. 232, n. 2, p. 257, doi. 10.1515/zpch-2017-0946
- By:
- Publication type:
- Article
Treatment of Grade II and III Actinic Keratosis Lesions with a Film-Forming Medical Device Containing Sunscreen/Piroxicam 0.8% and a Retinoic Acid/Glycolic Gel: A Pilot Trial.
- Published in:
- Dermatology & Therapy, 2018, v. 8, n. 3, p. 399, doi. 10.1007/s13555-018-0244-3
- By:
- Publication type:
- Article
Occupationally induced fixed drug eruption caused by a non-steroidal anti-inflammatory agent.
- Published in:
- Contact Dermatitis (01051873), 2012, v. 67, n. 3, p. 176, doi. 10.1111/j.1600-0536.2012.02089.x
- By:
- Publication type:
- Article
Cutaneous adverse drug reactions caused by delayed sensitization to carboxymethylcellulose.
- Published in:
- Contact Dermatitis (01051873), 2011, v. 64, n. 5, p. 294, doi. 10.1111/j.1600-0536.2011.01881.x
- By:
- Publication type:
- Article
Photopatch testing with an extended series of photoallergens: a 5-year study.
- Published in:
- Contact Dermatitis (01051873), 2009, v. 60, n. 6, p. 325, doi. 10.1111/j.1600-0536.2009.01550.x
- By:
- Publication type:
- Article
Piroxicam-induced erythema multiforme.
- Published in:
- 2004
- By:
- Publication type:
- Other
Fixed drug eruption from piroxicam with positive lesional patch test.
- Published in:
- Contact Dermatitis (01051873), 2002, v. 46, n. 3, p. 174, doi. 10.1034/j.1600-0536.2002.460309.x
- By:
- Publication type:
- Article
Piroxicam-β-cyclodextrin and photosensitivity reactions.
- Published in:
- Contact Dermatitis (01051873), 1998, v. 38, n. 4, p. 229
- By:
- Publication type:
- Article
Ampiroxicam-induced photosensitivity.
- Published in:
- Contact Dermatitis (01051873), 1996, v. 35, n. 2, p. 101, doi. 10.1111/j.1600-0536.1996.tb02300.x
- By:
- Publication type:
- Article
Ampiroxicam-induced photosensitivity.
- Published in:
- Contact Dermatitis (01051873), 1996, v. 34, n. 4, p. 298, doi. 10.1111/j.1600-0536.1996.tb02208.x
- By:
- Publication type:
- Article
Hypersensitivity to thimerosal: the sensitizing moiety.
- Published in:
- Contact Dermatitis (01051873), 1996, v. 34, n. 3, p. 201, doi. 10.1111/j.1600-0536.1996.tb02174.x
- By:
- Publication type:
- Article
What risk of piroxicam photodermatitis in thimerosal-positive patients?
- Published in:
- Contact Dermatitis (01051873), 1996, v. 34, n. 1, p. 60, doi. 10.1111/j.1600-0536.1996.tb02115.x
- By:
- Publication type:
- Article
Contact sensitivity to piroxicam.
- Published in:
- Contact Dermatitis (01051873), 1993, v. 29, n. 3, p. 167, doi. 10.1111/j.1600-0536.1993.tb03529.x
- By:
- Publication type:
- Article
Fixed drug eruption form piroxicam.
- Published in:
- Contact Dermatitis (01051873), 1993, v. 28, n. 1, p. 43, doi. 10.1111/j.1600-0536.1993.tb03329.x
- By:
- Publication type:
- Article
Photosensitivity to piroxicam: absence of cross-reaction with tenoxicam.
- Published in:
- Contact Dermatitis (01051873), 1992, v. 27, n. 5, p. 287, doi. 10.1111/j.1600-0536.1992.tb03281.x
- By:
- Publication type:
- Article
Contact allergy to piroxicam gel.
- Published in:
- Contact Dermatitis (01051873), 1992, v. 27, n. 4, p. 261, doi. 10.1111/j.1600-0536.1992.tb03262.x
- By:
- Publication type:
- Article
Thimerosal allergy and its relevance in Singapore.
- Published in:
- Contact Dermatitis (01051873), 1992, v. 26, n. 3, p. 195, doi. 10.1111/j.1600-0536.1992.tb00294.x
- By:
- Publication type:
- Article
Sensitivity to thimerosal and photosensitivity to piroxicam.
- Published in:
- Contact Dermatitis (01051873), 1991, v. 24, n. 3, p. 187, doi. 10.1111/j.1600-0536.1991.tb01696.x
- By:
- Publication type:
- Article
A probable role for vaccines containing thimerosal in thimerosal hypersensitivity.
- Published in:
- Contact Dermatitis (01051873), 1991, v. 24, n. 3, p. 178, doi. 10.1111/j.1600-0536.1991.tb01694.x
- By:
- Publication type:
- Article
Clinical evidence of cross-sensitivity between thiosalicylic acid, a contact allergen, and piroxicam, a photoallergen.
- Published in:
- Contact Dermatitis (01051873), 1989, v. 21, n. 5, p. 349, doi. 10.1111/j.1600-0536.1989.tb04764.x
- By:
- Publication type:
- Article
Tiaprofenic acid photodermatitis.
- Published in:
- Contact Dermatitis (01051873), 1989, v. 21, n. 5, p. 345, doi. 10.1111/j.1600-0536.1989.tb04761.x
- By:
- Publication type:
- Article
Lentinula edodes Mycelium as Effective Agent for Piroxicam Mycoremediation.
- Published in:
- Frontiers in Microbiology, 2019, p. N.PAG, doi. 10.3389/fmicb.2019.00313
- By:
- Publication type:
- Article
Acute localized exanthematous pustulosis: A novel side effect of piroxicam.
- Published in:
- Our Dermatology Online / Nasza Dermatologia Online, 2022, v. 13, n. 1, p. 65, doi. 10.7241/ourd.20221.15
- By:
- Publication type:
- Article
Effect of virgin olive oil versus piroxicam phonophoresis on exerciseinduced anterior knee pain.
- Published in:
- Avicenna Journal of Phytomedicine, 2016, v. 6, n. 5, p. 535
- By:
- Publication type:
- Article
Khaya senegalensis inhibits piroxicam mediated gastro-toxicity in wistar rats.
- Published in:
- Avicenna Journal of Phytomedicine, 2014, v. 4, n. 6, p. 377
- By:
- Publication type:
- Article
Absence of Interaction of Fondaparinux Sodium with Aspirin and Piroxicam in Healthy Male Volunteers.
- Published in:
- Clinical Pharmacokinetics, 2002, v. 41, n. 12, p. 31, doi. 10.2165/00003088-200241002-00005
- By:
- Publication type:
- Article
Absence of interaction of fondaparinux sodium with aspirin and piroxicam in healthy male volunteers.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Piroxicam selectively inhibits the growth of premalignant and malignant human oral cell lines by limiting their progression through the S phase and reducing the levels of cyclins and AP-1.
- Published in:
- International Journal of Cancer, 2003, v. 107, n. 5, p. 830, doi. 10.1002/ijc.11499
- By:
- Publication type:
- Article
Enhanced transdermal permeability of piroxicam through novel nanoemulgel formulation.
- Published in:
- International Journal of Pharmaceutical Investigation, 2014, v. 4, n. 2, p. 65, doi. 10.4103/2230-973X.133053
- By:
- Publication type:
- Article